I have not read much of this thread, but here's what I posted on another thread:
Hi Simon - I'm not privy to all of the details, but here's what I've gleaned. Vicky Whittemore seems to 'get it' - she understands the difference between chronic fatigue the symptom and ME/CFS the illness. But her boss, NINDS director Koroshetz, apparently does not get it. Now, I'm getting this second-hand so I can't 100% vouch for it. Various advocates have over the past few months had meetings with those two and have pushed for, a) a formalized role for patients and advocates in NIH research planning, and b) CCC criteria for the NIH clinical study. Neither suggestion has been acted on by the NIH team. Yesterday I sent a note to Dr. Collins explaining that things are not going well and NIH has a lot of work to do to get the patient community on board with what they're doing.
That said, yesterday Julie Rehmeyer heard from an NIH press officer that the clinical study protocol was mistakenly posted early. I hope this means there is still room for the NIH team to do a better job of listening to us. If they end up sticking with the protocol that was posted (it was not "announced" by NIH as some suggested...no one at NIH alerted anyone to it), I don't think it will be the total disaster some fear. If they do the 2-day exercise test properly, the study will find two groups of people - a group with PEM and a group without PEM. We already know these two groups exist, so the NIH is kind of reinventing the wheel here. It wouldn't be the first time an NIH intramural study unnecessarily replicated work done by outside researchers. They have a habit of doing that.
Several people are talking with the NIH team this week and expressing some of these sentiments. I hope they listen.
Brian
PS - On the positive side, the PI of the study is an expert in infections of the CNS. His name is Avindra Nath and he's known for discovering many of HIV's neurological impacts.
https://neuroscience.nih.gov/ninds/Faculty/Profile/avindra-nath.aspx